A-scan |
A-mode ultrasonography |
ABCB5 |
ATP-binding cassette sub-family B member 5 |
ADC |
Apparent diffusion coefficient |
AJCC |
American Joint committee on cancer |
AKT |
Protein kinase B |
ALIX |
Programmed cell death 6-interacting protein |
B-scan |
B-mode ultrasonography |
BAP1
|
BRCA1-associated protein |
CD |
Cluster of differentiation |
cfDNA |
Cell free DNA |
CM |
Cutaneous melanoma |
CNV |
Copy number variation |
CT |
Computed tomography |
CTC |
Circulating tumor cell |
ctDNA |
Circulating tumor DNA |
CTDSPL |
CTD small phosphatase like |
CTGF |
Connective tissue growth factor |
CTLA-1 |
cytotoxic T-lymphocyte-associated antigen 4 |
CYSLTR2
|
Cysteinyl Leukotriene Receptor 2 |
DCE-MRI |
Dynamic contrast-enhanced magnetic resonance imaging |
ddPCR |
Droplet digital PCR |
DJ-1 |
Parkinson disease protein 7 |
DNA |
Deoxyribonucleic acid |
dsDNA |
Double stranded DNA |
DW |
Diffusion-weighted |
ECM1 |
Extracellular matrix protein 1 |
EDI |
Enhanced depth imaging |
EIF1AX
|
Eukaryotic translation initiation factor 1A, X-linked |
EMT |
Epithelial to mesenchymal transition |
EpCAM |
Epithelial cell adhesion molecule |
EV |
Extracellular vesicles |
FDA |
Food and drug administration |
FDG |
Fluorodeoxyglucose |
FFPE |
Formalin-fixed paraffin-embedded |
FISH |
Fluorescence in situ hybridization |
FNAB |
Fine needle aspiration biopsy |
fSRT |
Fractionated stereotactic radiotherapy |
GNA11
|
G-protein α subunit 11 |
GNAQ
|
G-protein α subunit Q |
Gp100 |
Glycoprotein 100 |
HLA |
Human leukocyte antigen |
HOXA11 |
Homeobox 11 |
HTRA1 |
Serine proteoase HTRA1 |
IFN-γ |
Interferon gamma |
IGFBP1 |
Insulin-like growth factor-binding protein 7 |
IL |
Interleukin |
LAMA1 |
Laminin subunit alpha-1 |
LAMP1 |
Lysosome-associated membrane glycoprotein 1 |
LDH |
Lactate dehydrogenase |
MACS |
Magnetic activated cell sorting |
MAGED1 |
Melanoma-associated antigen D1 |
MAGED2 |
Melanoma-associated antigen D2 |
MCAM |
Melanoma cell adhesion molecule |
MCSP |
Melanoma-associated chondroitin sulfate proteoglycan |
MIA |
Melanoma inhibitory activity |
miR |
MicroRNA |
miRNA |
MicroRNA |
MITF |
Microphthalmia-associated transcription factor |
MLANA |
Melanoma antigen recognized by T-cells 1 |
MRI |
Magnetic resonance imaging |
mRNA |
Messenger RNA |
NCAM |
Neural cell adhesion molecules |
NDFIP1 |
Nedd4-family interactive protein 1 |
NHS |
National Health Service |
NRP2 |
Neuropilin-2 |
OCT |
Optical coherence tomography |
OS |
Overall survival |
OXPHOS |
Oxidative phosphorylation |
PAM |
Peptidyl-glycine alpha-amidating monooxygenase |
PBT |
proton beam therapy |
PD-1 |
Programmed cell death protein 1 |
PDHB |
Pyruvate dehydrogenase E1 subunit Beta |
PDT |
photodynamic therapy |
PET/CT |
Positron emission tomography/computed tomography |
PFS |
Progression free survival |
PI3K |
Phosphoinositide 3-kinase |
PLCB4
|
Phospholipase C beta 4 |
PTEN |
Phosphatase and Tensin homolog |
qNPA |
Quantitative nuclease protection assay |
RNA |
Ribonucleic acid |
ROMS |
Rotterdam Ocular Melanoma Study group |
RT-PCR |
Reverse transcription polymerase chain reaction |
RT2-array |
Qiagen RT2 miRNA PCR array (brain cancer panel) |
S-100β |
S100 calcium binding protein beta |
SDHA |
Succinate dehydrogenase |
SERPINE1 |
Plasminogen activator inhibitor, type 1 |
SF3B1
|
Splicing factor 3B unit 1 |
SMART-seq |
Switching Mechanism at 5′ end of RNA Template |
sWGS |
Shallow whole genome sequencing |
THBS2 |
Thrombospondin 2 |
TLDA |
Taqman low density array |
TOP2A |
DNA topoisomerase IIa |
TTT |
Transpupillary thermotherapy |
UK |
United Kingdom |
ULBP2 |
UL16-binding protein 2 |
UM |
Uveal melanoma |
US |
Ultrasonography |
V |
Protein V homolog |
VA |
Visual acuity |
VEGF |
Vascular endothelial growth factor |
VGF |
VGF nerve growth factor inducible |
VH |
Vitreous humor |
γGT |
Gamma glutamyl transferase |